Georgakis, Marios K.
Malik, Rainer
Bounkari, Omar El
Hasbani, Natalie R.
Li, Jiang
Huffman, Jennifer E.
Shakt, Gabrielle
Tack, Reinier W. P.
Kimball, Tamara N.
Asare, Yaw
Morrison, Alanna C.
Tsao, Noah L.
Judy, Renae
Mitchell, Braxton D.
Xu, Huichun
Montasser, May E.
Do, Ron
Kenny, Eimear E.
Loos, Ruth J. F.
Terry, James G.
Carr, John Jeffrey
Bis, Joshua C.
Psaty, Bruce M.
Longstreth, W. T.
Young, Kendra A.
Lutz, Sharon M.
Cho, Michael H.
Broome, Jai
Khan, Alyna T.
Wang, Fei Fei
Heard-Costa, Nancy
Seshadri, Sudha
Vasan, Ramachandran S.
Palmer, Nicholette D.
Freedman, Barry I.
Bowden, Donald W.
Yanek, Lisa R.
Kral, Brian G.
Becker, Lewis C.
Peyser, Patricia A.
Bielak, Lawrence F.
Ammous, Farah
Carson, April P.
Hall, Michael E.
Raffield, Laura M.
Rich, Stephen S.
Post, Wendy S.
Tracy, Russel P.
Taylor, Kent D.
Guo, Xiuqing
Mahaney, Michael C.
Curran, Joanne E.
Blangero, John
Clarke, Shoa L.
Haessler, Jeffrey W.
Hu, Yao
Assimes, Themistocles L.
Kooperberg, Charles
Bernhagen, Jürgen
Anderson, Christopher D.
Damrauer, Scott M.
Zand, Ramin
Rotter, Jerome I.
de Vries, Paul S.
Dichgans, Martin
Funding for this research was provided by:
Klinikum der Universität München
Article History
Received: 27 June 2024
Accepted: 11 March 2025
First Online: 21 March 2025
Declarations
:
: All studies have received ethical approvals from the respective ethical authorities and participants in all studies have provided written informed consent. Data from the UKB are available upon submission and approval of a research proposal. The UKB has institutional review board approval from the Northwest Multi‐Center Research Ethics Committee (Manchester, UK). deCODE has been approved by the National Bioethics Committee of Iceland, and the study was conducted in agreement with conditions issued by the Data Protection Authority of Iceland (VSN_14-015). All common research protocols for the TOPMed Program have been approved by the institutional review board at the University of Maryland Baltimore, whereas individual participating studies have obtained ethical approval from their local ethical authorities, as described previously []. The Penn Medicine BioBank is approved by the University of Pennsylvania under IRB protocol# 813913, MVP by the Veterans Affairs Central Institutional Review Board, the Geisinger DiscovEHR-MyCode cohort by Geisinger Institutional Review Boards, and MGBB by the Ethics Committee of Mass General Brigham.
: Not applicable.
: MKG has received consulting fees from Tourmaline Bio Inc., and Gerson Lehrman Group Inc. (unrelated to this work) and is a member of the Editorial Board of Neurology. SMD receives research support from RenalytixAI and personal fees from Calico Labs, both outside the current work. MEM receives funding from Regeneron Pharmaceutical Inc. unrelated to this work. RD has received research support from AstraZeneca and Goldfinch Bio, not related to this work. BMP serves on the Steering Committee of the Yale Open Data Access Program funded by Johnson & Johnson. CDA has received sponsored research support from Bayer AG, has consulted for ApoPharma, and is a member of the Editorial Board of Neurology. LMR is a consultant for the TOPMed Administrative Coordinating Center (through WeStat). The remaining authors have no conflicts of interest to disclose.